Development of thioquinazolinones, allosteric Chk1 kinase inhibitorsAntonella Converso, George D. Hartman, Timothy J. Hartingh et al.|Bioorganic & Medicinal Chemistry Letters|2008Cited by 74
Kinesin spindle protein (KSP) inhibitors. Part 2: The design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSPMark E. Fraley, George D. Hartman, Hans E. Huber et al.|Bioorganic & Medicinal Chemistry Letters|2006Cited by 64
Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSPKeith Rickert, Carolyn A. Buser, R. M. Garbaccio et al.|Archives of Biochemistry and Biophysics|2007Cited by 50
Kinesin spindle protein (KSP) inhibitors. Part 3: Synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubilityR. M. Garbaccio, George D. Hartman, Christy M. Olson et al.|Bioorganic & Medicinal Chemistry Letters|2006Cited by 47
Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitorsEdward J. Brnardic, Constantine Kreatsoulas, Mark E. Fraley et al.|Bioorganic & Medicinal Chemistry Letters|2007Cited by 44